Ayurvedic management of vata rakta(Gout) by Siravedhana and Mustadi Yapana Basti

A Randomized Comparative Clinical Study Evaluating the Efficacy of siravedhana followed by Modified Bala Guduchyadi Yapana Basti and Mustadi Yapana Basti in the Management of Vatarakta wsr to Gout - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088989

Enrollment

Registered

2025-06-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects presenting with classical clinical features of Vatarakta. 2. Subjects of either gender between age group of 18-70 yr. 3. Subjects fit for Niruha and Anuvasna basti karma. 4. Uric Acid level ABove 6 mg /dl in female. 5. Uric acid level ABove 7 mg/dl in male.

Exclusion criteria

Exclusion criteria: 1. Subjects with chronic autoimmune disease of joints & with joint deformity due to it 2. Subjects with uncontrolled metabolic systemic disorder like HTN and DM 3. Pregnant and lactating women. 4. Subjects contraindicated for Niruha and Anuvasana Basti. 5. Subjects with Alpa bala.

Design outcomes

Primary

Measure	Time frame
Reduction in symptoms of VataraktaTimepoint: 4th day of treatment- first follow up and assesment of parameters 20th day of treatment- second follow up and assesment of parameters	—

Secondary

Measure	Time frame
Reduction in uric acid levelsTimepoint: 4th day of treatment- first follow up & assesment of parameters 20th day of treatment- second follow up & assessment of parameters	—

Countries

India

Contacts

Public ContactDr Sangeeta H Toshikhane

Parul institute of ayurved

sangeeta.toshikhane26791@paruluniversity.ac.in9964596479

Outcome results